ARCH PHARMALABS LIMITED

ARCH PHARMALABS LIMITED (CIN: U24231MH1993PLC150891) is a Public company incorporated on 02 Apr 1993. It is classified as a Company limited by shares company and is registered at Registrar of Companies, ROC Mumbai. Its authorized share capital is Rs. 30000000000.00 and its paid-up capital is Rs. 1564807680.00.
ARCH PHARMALABS LIMITED's Annual General Meeting (AGM) was last held on 29 Dec 2023 and, as per records from the Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 31 Mar 2023.
ARCH PHARMALABS LIMITED's NIC code is 24231. As per the NIC code, it is involved in .
The registered address of ARCH PHARMALABS LIMITED is Unit No. 301,302 and 303, H Wing 3rd Floor, Tex Centre ,,Off Saki Vihar Road, Chandivali, Andheri East, Mumbai,Mumbai,Mumbai,Mumbai,Maharashtra,India,400072.
Current status: Under CIRP.

Basic Information

CIN/LLPIN/FCRN:	U24231MH1993PLC150891
ROC Code:	ROC Mumbai
Company Class:	Public
Company Category:	Company limited by shares
Activity Description:	No Data Available
Active Compliance:	ACTIVE compliant

Annual Compliance Status

Date of Inc.:	04/02/1993
Date of AGM:	12/29/2023
Date of B/S:	03/31/2023
Company Status:	Under CIRP
Industry:	No Data Available
Registered address:	Unit No. 301,302 and 303, H Wing 3rd Floor, Tex Centre ,,Off Saki Vihar Road, Chandivali, Andheri East, Mumbai,Mumbai,Mumbai,Mumbai,Maharashtra,India,400072

Key Numbers

Authorised Capital:	30000000000
Paid up Capital:	1564807680
Listing Status:	Unlisted
Filing status:	ACTIVE compliant
NIC Code:	24231

Previous Name

Previous Company Name:

ARCH PHARMALABS LIMITED

Previous CIN

Previous CIN:

U24231MH1993PLC150891

Regulatory Filings for ARCH PHARMALABS LIMITED

In India, every company must submit a variety of documents such as financial statements, loan contracts, shareholder lists, director details, funding rounds, and more. These documents provide reliable and valuable insights into a company's operations. However, going through them to assess a company's standing can be an overwhelming and time-consuming task.

Our reports are crafted to help you save valuable time by highlighting essential information and organizing it in a way that simplifies your research process.

Grasping the critical insights from our reports can be vital for anyone involved with ARCH PHARMALABS LIMITED, whether you’re a customer, vendor, investor, partner, or even a prospective employee.

Access the complete report for ARCH PHARMALABS LIMITED

Litigation Report for ARCH PHARMALABS LIMITED

Obtain a detailed list of all legal cases that ARCH PHARMALABS LIMITED is currently involved in or has been part of in the past. The litigation search report is essential for anyone considering working with ARCH PHARMALABS LIMITED, whether as a vendor, employee, or customer. It provides crucial information about the legal risks associated with doing business with ARCH PHARMALABS LIMITED and its directors.

Our search encompasses both civil and criminal cases, covering over 670 courts and institutions, including the Supreme Court, High Courts, District Courts, Tribunals, and more. Click here to explore the full list of covered courts and organizations.

Access the full Litigation Search Report for ARCH PHARMALABS LIMITED

Outstanding Payments to Micro & Small Enterprises

It is mandatory for companies to submit bi-annual returns detailing payments owed to Micro & Small Enterprises that are overdue by more than 45 days. This data is essential for assessing whether ARCH PHARMALABS LIMITED makes timely payments to its suppliers. Analyzing this information over time can reveal whether the company has been delaying payments to its smaller vendors. Such details are only accessible if the company has filed its bi-annual returns with the Registrar of Companies.

Filing Type	As On	Amount Due to MSME	Current Liabilities	Ratio to Current Liabilities	Reasons for Delay

Investor Complaints & Serious Complaints About ARCH PHARMALABS LIMITED

This section provides information on investor or serious complaints lodged with the Registrar of Companies. Such data can help identify possible warning signs or concerns regarding the company.

Director Complaints

Date	DIN	Cessation Date	Cessation Reason	Complaint

Serious Complaints

Date	Complaint	Other Details

Investor Complaints & Other Complaints

Date	Complaint Type	Complaint Sub Type	Particulars of Securities	Period	Complaint	Other Details

Directors
DIN	Name	Role	Appointment Date
00636500	VIKAS BIJAY KEDIA	Company Secretary	2017-11-18
00032839	RAJENDRAKUMAR PADMANABHAN KAIMAL	CFO	2019-05-30
00032839	RAJENDRAKUMAR PADMANABHAN KAIMAL	Whole-time director	2018-11-01
00032799	AJIT ANNU KAMATH	Managing Director	2018-11-01
07028212	SUNIL MANSUKHLAL PITRODA	Director	2018-12-29
00012613	ASHISH MOHAN UJAGARE	Whole-time director	2018-12-29

Charges
Charge ID	Status	Date of Creation	Date of Satisfaction
100571158	Open	03/29/2022	No Data Available
100190938	Open	12/04/2017	No Data Available
10033687	Open	01/05/2007	No Data Available
100463954	Open	07/20/2021	No Data Available
100464383	Open	05/27/2021	No Data Available
10141795	Open	01/02/2009	No Data Available
10141812	Open	02/11/2009	No Data Available
10151719	Open	02/25/2009	No Data Available
10168628	Open	07/20/2009	No Data Available
10178818	Open	09/04/2009	No Data Available
10179653	Open	09/22/2009	No Data Available
10195697	Open	01/20/2010	No Data Available
10208613	Open	03/09/2010	No Data Available
10217401	Open	03/12/2010	No Data Available
10220633	Open	03/17/2010	No Data Available
10252029	Open	09/28/2010	No Data Available
10259226	Open	12/27/2010	No Data Available
10277742	Open	03/31/2011	No Data Available
10280176	Open	04/07/2011	No Data Available
10284060	Open	04/25/2011	No Data Available
10308055	Open	09/24/2011	No Data Available
10309033	Open	08/19/2011	No Data Available
10313029	Open	02/28/2011	No Data Available
10314741	Open	10/21/2011	No Data Available
10325469	Open	12/20/2011	No Data Available
10351928	Open	03/28/2012	No Data Available
10378613	Open	09/27/2012	No Data Available
10410251	Open	01/14/2013	No Data Available
10412345	Open	02/05/2013	No Data Available
10416734	Open	03/21/2013	No Data Available
10420997	Open	04/24/2013	No Data Available
10437722	Open	06/20/2012	No Data Available
10442042	Open	07/16/2013	No Data Available
10450741	Open	09/27/2013	No Data Available
80006999	Open	12/20/1999	No Data Available
80009270	Open	12/31/2004	No Data Available
80009718	Open	05/04/2005	No Data Available
80010619	Open	03/10/2005	No Data Available
80010762	Open	03/10/2005	No Data Available
80006735	Closed	06/22/2004	08/05/2009
10372485	Open	07/27/2012	No Data Available
10369965	Open	07/12/2012	No Data Available
10165686	Closed	07/08/2009	01/09/2010
10022896	Closed	10/23/2006	05/06/2010
10021459	Closed	09/23/2006	09/21/2007
10014877	Open	07/21/2006	No Data Available
10256576	Closed	10/04/2010	03/04/2011
10139458	Open	01/22/2009	No Data Available
10191813	Closed	12/03/2009	08/20/2010
10069156	Open	08/30/2007	No Data Available
80006941	Closed	12/12/2005	10/15/2010
10140594	Closed	01/17/2009	02/09/2010
10356919	Open	05/02/2012	No Data Available
10333606	Open	01/30/2012	No Data Available
10330785	Open	12/14/2011	No Data Available
10302745	Open	08/17/2011	No Data Available
10221279	Closed	04/28/2010	03/17/2011
10184411	Closed	10/30/2009	02/11/2012
10182487	Open	10/10/2009	No Data Available
10168156	Closed	07/21/2009	01/31/2012
10153483	Closed	03/25/2009	10/08/2011
10143830	Open	04/08/2008	No Data Available
10059458	Closed	07/03/2007	06/10/2011
10059452	Open	07/04/2007	No Data Available
10017376	Closed	08/30/2006	12/07/2011

Prosecution Details of ARCH PHARMALABS LIMITED
S.No.	Defaulting Entities	Court Name	Prosecution Section	Date of Order	Status

Balance Sheet

Financial data is accessible only if the company has submitted its filings. In the absence of filed returns, financial details for the respective period will not be provided.

Category	2024-03-31	2023-03-31	2022-03-31	2021-03-31	2020-03-31	2019-03-31	2018-03-31
Equity and Liabilities
Shareholder's Funds
Share Capital
Reserves & Surplus
Money Received Against Share Warrants
Share Application Money Pending Allotment
Non-current Liabilities
Long-term Borrowings
Deferred Tax Liabilities
Other Long Term Liabilities
Long Term Provisions
Current Liabilities
Short-term Borrowings
Trade Payables
Other Current Liabilities
Short Term Provisions
Total Equity and Liabilities
Assets
Non-current Assets
Fixed Assets
Tangible Assets
Intangible Assets
Capital Work In Progress
Intangible Assets Under Development
Non-current Investments
Deferred Tax Assets (net)
Long-term Loans & Advances
Other Non-current Assets
Current Assets
Current Investments
Inventories
Trade Receivables
Cash & Cash Equivalents
Short-term Loans & Advances
Other Current Assets
Total Assets

Profit & Loss Statement of ARCH PHARMALABS LIMITED
Financial data is accessible only if the company has submitted its filings. If the company has not filed its returns, financial information for the corresponding period will not be available.
Category	2024	2023	2022	2021	2020	2019	2018
Download Audited Financials
REVENUE FROM OPERATIONS
Domestic Turnover
Sale of Goods Manufactured
Sale of Goods Traded
Sale of Supply of Services
Export Turnover
Sale of Goods Manufactured
Sale of Goods Traded
Sale or Supply of Services
Other Income
Total Revenue from Operations
EXPENSES
Cost of Materials Consumed
Purchases of Stock in Trade
Change in Inventories of
Finished Goods
Work in Progress
Stock in Trade
Employee Benefit Expenses
Managerial Remuneration
Payment to Auditors
Insurance Expenses
Power & Fuel
Finance Cost
Depreciation & Amortization Expenses
Other Expenses
Total Expenses
Profit before Exceptional Items, Extraordinary Items and Tax
Exceptional Items
Profit before Extraordinary Items and Tax
Extraordinary Items
Profit before Tax
Tax Expense
Current Tax
Deferred Tax
Profit/Loss after Tax from Continuing Operations
Profit/Loss after Tax from Discontinuing Operations
Tax Expense of Discontinuing Operations
Total Profit/Loss
Earnings per Equity Share (EPS) before Extraordinary Items
Basic
Diluted
Earnings per Equity Share (EPS) after Extraordinary Items
Basic
Diluted

Fund Raising Activity of ARCH PHARMALABS LIMITED

This section provides information on the cash raised through the allocation of equity or debentures, including funds raised via Venture Capital. Additional details, such as investor names, are available in the attachments. This data is accessible only if the company has raised funds through the cash allotment of equity or debentures.

Date of Allotment	Securities Alloted	Terms	Number of Securities	Nominal Amount	Premium Amount Due & Payable	Premium Amount Paid	Total Discount	Amount to be Paid on Calls (Excluding Premium)	Attachments

Subsidiaries, Associate Companies & Joint Ventures of ARCH PHARMALABS LIMITED

This section provides a list of the company's associate companies and joint ventures based on the latest available annual returns. If the company has not filed annual returns or does not have any subsidiaries or joint ventures, this information will not be available.

Company Identifier	Name	Percentage of Shares Held

Board Meetings of ARCH PHARMALABS LIMITED

This section provides a list of board resolutions submitted by the company to the Registrar of Companies.

Date of Filing	Date of Dispatch of Notice	Date of Passing Resolution	Section (Companies Act 2013)	Section (Companies Act 1956)	Subject Matter of Resolution	Resolution Agreed By	Resolution Type	Additional Documents

Contact Details of ARCH PHARMALABS LIMITED

Email ID:	No Data Available
Website:	Not Available
Address:	Unit No. 301,302 and 303, H Wing 3rd Floor, Tex Centre ,,Off Saki Vihar Road, Chandivali, Andheri East, Mumbai,Mumbai,Mumbai,Mumbai,Maharashtra,India,400072

Auditors of ARCH PHARMALABS LIMITED

This section provides details of the auditors associated with the company over the years. Such information is accessible only if the company has submitted its annual returns to the Registrar of Companies.

Financial Year	Name of Auditor or Firm	PAN of Auditor or Firm	Membership Number / Registration Number	Name of Auditor Signing Report	Membership Number of Auditor Signing Report

View this company on

Finanvo Technowire